Ovarian cancer cells express programmed death ligand 1 (PDL-1) that binds to programmed death (PD-1) of CD8+ T cells and subsequently impairs the effector function of lymphocytes (Matsuzaki et al., 2010). The gene discussed is CD8A; the disease is ovarian carcinoma.